Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Oxford BioDynamics, Google Cloud Partner to Accelerate Cloud-Based Analytical Frameworks for Precision Medicine | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Oxford BioDynamics, Google Cloud Partner to Accelerate Cloud-Based Analytical Frameworks for Precision Medicine

Collaboration aims to scale OBD's analytical framework by leveraging Google Cloud's infrastructure.

Author Image

By: Charlie Sternberg

Associate Editor, Contract Pharma

Oxford BioDynamics (OBD) has partnered with Google Cloud to expand the capabilities of its 3D genomic biomarker technology. The collaboration aims to scale OBD’s analytical framework by leveraging Google Cloud’s infrastructure, enabling the biotech firm to provide high-throughput, AI-powered 3D genomic analytics to its partners in the pharmaceutical and biotechnology sectors.

The partnership will see Google Cloud provide cloud computing support, allowing OBD to enhance its proprietary EpiSwitch knowledge base and analytical tools. This move is part of OBD’s broader digital transformation strategy and is expected to facilitate faster access to predictive genomic insights for drug development and diagnostics.

Iain Ross, OBD’s Executive Chairman, said, “Working with Google Cloud allows OBD to rapidly scale its analytical capabilities, bringing it closer to delivering precision 3D genomics insights in real time.” He added, “We are excited to develop a powerful and interoperable platform that aligns with the future of cloud-native biomedical research.”

The resources provided by Google Cloud will support the deployment of containerized applications, integration with Google Cloud’s AI/ML tools, and the creation of secure, scalable data processing pipelines. These pipelines are designed to meet healthcare compliance standards, making OBD’s EpiSwitch platform more accessible to its industry partners and paving the way for future commercialization opportunities.

OBD’s EpiSwitch platform is a clinically validated technology that identifies regulatory changes in 3D genome architecture, which can be used to detect disease signatures and aid in target development.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics